Continuous subcutaneous insulin infusion: Experience from a large specialist service

Practical Diabetes International

Volumn 26, Issue 2, 2009, Pages 60-64

  Chellamuthu, P ^a   Lawrence, I G ^a   Kitchener, D ^a   McNally, P G ^a   Gregory, R ^a   Jackson, S ^a   Kong, M F ^a   Jarvis, Janet ^a,b   Davies, M J ^c  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Audit; CSII; Diabetes mellitus; Insulin pump therapy; NICE guidance; Patient education

Indexed keywords

HEMOGLOBIN A1C; INSULIN; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; LONG ACTING INSULIN;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTINUOUS INFUSION; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HEALTH SERVICE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN PUMP; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL SPECIALIST; PATIENT EDUCATION; PATIENT SATISFACTION; PRACTICE GUIDELINE; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK REDUCTION; TEACHING HOSPITAL; TERTIARY HEALTH CARE;

EID: 66149143992     PISSN: 13578170     EISSN: 1528252X     Source Type: Journal    
DOI: 10.1002/pdi.1337     Document Type: Article

References (28)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-985.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
3. Pickup JC, Keen H, Parsons JA, et al. Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. BMJ 1978; 1: 204-207.
4. Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: Meta-analysis of randomised controlled trials. BMJ 2002; 324: 705-708.
5. Weissberg-Benchell J, Antisdel-Lamaglio J, Sheshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care 2003, 26: 1079-1087.
6. Doyle EA, Weinzimer SA, Steffen AT, et al. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004; 27: 1554-1558.
7. Hirsch IB, Bode BW, Garg S, et al. Continuous subcutaneous insulin infusion of insulin aspart versus multiple daily injections of insulin aspart/insulin glargine in type 1 diabetic patients previously untreated with CSII. Diabetes Care 2005; 28: 533-538.
8. Bolli GB, Capani F, Home PD, et al. Comparison of a multiple daily injection regimen with once daily insulin glargine basal insulin and mealtime lispro, to continuous subcutaneous insulin infusion: a randomised, open, parallel study. Diabetes 2004; 53(Suppl 2): A107.
9. National Institute for Clinical Excellence (NICE). Guidance on the use of continuous subcutaneous insulin infusion for diabetes. Technology Appraisal Guidance No 57. London: NICE, 2003.
10. National Institute for Health and Clinical Excellence (NICE). Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus. Technology Appraisal Guidance No 151. London: NICE, July 2008. http://www.nice.org.uk/Guidance/TA151
11. Garg R, Johnston V, McNally PG, et al. Practical aspects in the usage of U-500 insulin. Pract Diabetes Int 2006; 23: 118-121.
12. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. DAFNE Study Group. BMJ 2002; 325: 746.
13. Dartford and Gravesham NHS Trust/Dartford, Gravesham and Swanley PCT. Insulin pump therapy questionnaires; Provision of insulin pump therapy. Ref DIAB 003 (v0.1) August 2004. http://www.dvh.nhs.uk
14. National Institute for Clinical Excellence (NICE). The clinical effectiveness and cost effectiveness of patient education models for diabetes. Technology Appraisal Guidance No 60. London: NICE, 2003.
15. Insulin infusion pump therapy: http://www.leicestershirediabetes.org.uk
16. Retnakaran R, Hochman J, DeVries JH, et al. Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c. Diabetes Care 2004; 27: 2590-2596.
17. Pickup JC. Point: Are insulin pumps underutilized in type 1 diabetes? Yes. Diabetes Care 2006; 29: 1449-1452.
18. Pickup JC, Kidd J, Burmiston S, et al. Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability. Diabetes Metab Res Rev 2006; 22: 232-237.
19. Hammond P. NICE guidance on insulin pump therapy: time for a re-appraisal? Pract Diabetes Int 2005; 22: 115-116.
20. Bode BW, Steed RD, Davidson PC. Reduction in severe hypoglycaemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care 1996; 19: 324-327.
21. Boland EA, Grey M, Oesterle A, et al. Continuous subcutaneous insulin infusion: a new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 1999; 22: 1799-1784.
22. Linkeschova R, Raoul M, Bott U, et al. Less severe hypoglycaemia, better metabolic control, and improved quality of life in type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy: an observational study of 100 consecutive patients followed for a mean of 2 years. Diabet Med 2002; 19: 746-751.
23. Lawrence IG, Philips S, Davies MJ, et al. Long-term improved glycaemic control following attendance on a Dose Adjustment For Normal Eating (DAFNE) course. Diabet Med 2008; 25(Suppl 1): 72.
24. Hopkins D, Lawrence IG, Amiel S, et al. Routine structured education reduces HbA1c & hypoglycaemia and improves psychological health in patients with type 1 diabetes. ADA 68th Scientific Sessions, San Francisco, 6-10 June 2008. Abstract 121-OR.
25. Mecklenburg RS, Benson EA, Benson JW Jr, et al. Acute complications associated with insulin pump therapy: report of experience with 161 patients. JAMA 1984; 252: 3265-3269.
26. Knight G, Jennings AM, Boulton AJM, et al. Severe hyperglycaemia and ketoacidosis during routine treatment with an insulin pump. BMJ 1985; 291: 371-372.
27. Chantelau E, Spraul M, Mühlhauser I, et al. Long-term safety, efficacy and side effects of continuous subcutaneous insulin infusion treatment for type 1 (insulin-dependent) diabetes mellitus: a one centre experience. Diabetologia 1989; 32: 421-426.
28. Bending JJ, Pickup JC, Keen H. Frequency of diabetic ketoacidosis and hypoglycemic coma during treatment with continuous subcutaneous insulin infusion. Am J Med 1985; 79: 685-691.